Obi Greenman
Vermögen: 15 Mio $ am 30.06.2026
Vermögen: 15 Mio $ am 30.06.2026
William Mariner Greenman is Executive Chairman at Cerus Corp.
since 2026.
Former roles include Independent Director at Aduro BioTech, Inc., Independent Director at Chinook Therapeutics, Inc. from 2010 to 2023, and Senior Vice President-Biotech Division at Baxter International, Inc. in 1995.
Education includes undergraduate studies at Stanford University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CERUS CORPORATION 2.52% | 30.06.2026 | 5’053’036 ( 2.52% ) | 15 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CERUS CORPORATION | Vorsitzender | 16.03.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.08.2023 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.1995 |
| CHINOOK THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen